Does Rallies show INTS price targets?

Yes. Rallies tracks INTS analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.

Is INTS research on Rallies investment advice?

No. Rallies provides research, data, and educational context for INTS. It does not provide personalized investment advice.

INTS (Intensity Therapeutics, Inc. Common stock) Stock Analysis - Analyst Ratings

Intensity Therapeutics, Inc. Common stock (INTS) is a publicly traded Healthcare sector company. As of May 21, 2026, INTS trades at $4.58 with a market cap of $12.38M and a P/E ratio of -0.54. INTS moved +0.87% today. Year to date, INTS is -53.23%; over the trailing twelve months it is -55.35%. Its 52-week range spans $4.50 to $100.00. Analyst consensus is buy with an average price target of $25.00. Rallies surfaces INTS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate INTS?

2 analysts cover INTS: 0 strong buy, 2 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is buy. The average price target is $25.00.

INTS Key Metrics

Key financial metrics for INTS
Metric	Value
Price	$4.58
Market Cap	$12.38M
P/E Ratio	-0.54
EPS	$-8.56
Dividend Yield	0.00%
52-Week High	$100.00
52-Week Low	$4.50
Volume	25.07K
Avg Volume	0
Revenue (TTM)	$0
Net Income	$-11.61M
Gross Margin	0.00%

INTS Analyst Consensus

2 analysts cover INTS: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $25.00.

Latest INTS News

Intensity Therapeutics Wins 2026 Cancer Treatment Technology Innovator Award — May 14, 2026
Intensity Therapeutics Reports Q1 Net Loss $2.4M, 71.4% pCR in TNBC Study — May 7, 2026
Intensity Therapeutics Earns Platinum Pinnacle Award for INT230-6 Intratumoral Platform — Apr 15, 2026
Intensity Raises $20M, Extends Runway to Q2 2027; 71% pCR in TNBC — Mar 27, 2026
Intensity Therapeutics Secures US Patent No. 12,496,345, Expands IP to 41 Countries — Mar 24, 2026

Common questions about INTS

What do analysts rate INTS?: 2 analysts cover INTS: 0 strong buy, 2 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is buy. The average price target is $25.00.
Does Rallies show INTS price targets?: Yes. Rallies tracks INTS analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is INTS research on Rallies investment advice?: No. Rallies provides research, data, and educational context for INTS. It does not provide personalized investment advice.